Nobi Smart Lights Secures
€35 Million in Oversubscribed Series B Funding
Trend: rising demand for AI in tackling global aging challenges
Antwerp, January 28, 2025 – Amid the increasing demand for AI-driven solutions to tackle global aging challenges, the European AgeTech company ‘Nobi’ announces the successful close of its oversubscribed €35 million Series B funding. This milestone comes just weeks after the announcement of Nobi’s groundbreaking partnership with Frontier Management, one of the largest senior care providers in the US, highlighting the growing trust in Nobi’s innovative AI-lights for fall prevention & smart care.
Investors With a Mission
In its ambition to scale further and create a global impact, Nobi has secured exceptional new partner-investors. They will support Nobi in strengthening market leadership and enhance the platform with new features to improve care home workflows. Nobi’s investment round was co-led by Angelini Ventures and Nexus NeuroTech Ventures, with support from Japanese investor 15th Rock. Existing investors, including EQT Health Economics and EQT Dementia Fund -two fund strategies of EQT Life Sciences-, Belgian investment company PMV, and Nobi’s founders Roeland Pelgrims and Bert De Haes, also participated. Co-founding business angel Balz Halter as well reaffirmed his commitment by contributing to the Series B round.
Global Challenges Meet Global Collaboration: Japan, Europe, and the US Unite
Together, Nobi’s investor base spans continents—from Asia over Europe to the US, this global reach underscores a shared belief in Nobi’s potential to transform senior care.
“This funding milestone is yet another proof of the overwhelming need for AgeTech solutions that combine gold standard technology with award winning design.” said Roeland Pelgrims, CEO and Co-founder of Nobi. “Having such a diverse group of world-class investors and an all-star board reaffirms the global potential of our mission.”
Transforming AI-lights
Society is aging fast. By 2030, one in five Americans[1] and Europeans[2] will be over the age of 65, while in the UK, this figure will rise to one in four by 2040. In Japan—home to the world’s oldest population—one in three people is already over 65[3]. These shifts strain healthcare systems worldwide, creating urgent demand for innovative solutions. Nobi’s mission is to help older adults live happily, independently, and with dignity. From enabling seniors to stay at home longer to supporting them in professional care environments, Nobi serves as a guardian angel for seniors and a partner for caregivers. Nobi looks like a simple light almost invisibly hanging in the middle of the room. But underneath the lampshade, there’s a life-saving AI universe that works in real-time, processing data locally to ensure better privacy and reliability. The AI model was trained for 6 years by the world’s best AI experts on more than 250,000 real-life situations with only 1 ambition: making impact in the lives of elderly people and their caregivers.
Speed Saves Lives
Rapid intervention after a fall is critical, as long-lie periods—when individuals remain on the floor for over an hour—significantly increase the risk of complications or death. Studies show that waiting over an hour raises the likelihood of mortality within six months to 50%. A recent analysis[1] highlights Nobi’s impact. The smart lights enable caregivers to respond 94% faster: reducing waiting times from 1 hour and 8 minutes to just 4 minutes. Before Nobi, 44% of falls involved long-lie periods over an hour. With Nobi, these incidents were eliminated, ensuring residents receive timely care and relieving caregivers of the stress of finding residents waiting for hours.
Prevent 4 Out of 5 Falls
The analysis revealed that Nobi reduces falls by 51% immediately after installation. At Hartland House, a UK care home, Nobi even reduces falls by 84% following the activation of additional prevention measures in a second phase. Preventing 4 out of 5 falls led the regional government to adopt Nobi in 50 additional care homes across Lancashire & South-Cumbria. Watch this video to learn more about the government’s decision to scale Nobi across the region.
Investor Insights
William Marks, General Partner, Co-Founder, and Chief Medical Officer at Nexus NeuroTech Ventures, commented: "At Nexus NeuroTech, we invest in technology-based solutions to improve the lives of people with neurological conditions, such as Parkinson's disease. Nobi represents a great opportunity to have an immediate and direct positive impact on the lives of people with these conditions, and the aging population in general–where falls and associated morbidity are common."
Tanja Dowe, Managing Director of Angelini Ventures, added: “Nobi's technology stands out by seamlessly integrating AI and advanced monitoring capabilities with a deep understanding of elderly care needs. Nobi delivers meaningful, clinically validated improvements to daily care operations in assisted living facilities and care homes, supporting both residents and caregivers. We also appreciate the ability to harness the Nobi platform beyond fall management, extending its use to more expansive health and disease monitoring, as well as care management."
Japan: A Strategic Market for Growth
As the world’s oldest society and a front-runner in AgeTech, Japan presents unparalleled opportunities for innovation.
“15th Rock is excited to help Nobi expand its business and collaboration network in Japan,” says Tetsu Nakajima, Founder & General Partner of 15th Rock.
Press Visuals
Press visuals: download here
About Nobi Smart Lights
Founded in Belgium in 2018, Nobi is an AgeTech company dedicated to helping people age with dignity, safety, and happiness. Nobi’s flagship product, its award-winning AI-powered smart light, delivers innovative solutions for fall detection, fall prevention, and smart care. Currently employing 50 full-time equivalents (FTEs), Nobi plans to expand its team to 80 FTEs by the end of 2025. With offices in Belgium, the US, and the UK, Nobi’s solutions are available in over 22 countries.
About Nexus NeuroTech Ventures
Nexus NeuroTech Ventures invests in transformative technologies aimed at improving the lives of people with brain disorders. By targeting innovative solutions in medical devices, software, and diagnostics, Nexus seeks to drive advancements in neurodevelopmental, neurodegenerative, and neuropsychiatric care.
https://www.nexusneurotech.com/
About Angelini Ventures
Angelini Ventures, the venture capital arm of Angelini Industries, is a Series A and Series B investment firm focused on accelerating disruptive innovations and trends in BioTech and Digital Health. Angelini Ventures will invest €300 million across a global portfolio in Europe and North America, drawing on a global team, strategic advisors and partners to help entrepreneurs scale their businesses into transformative category-leading companies. To date, Angelini Ventures has invested around €100 million into 18 companies covering a range of therapeutic areas and modalities, including Neumirna, Cour Pharmaceuticals, Noctrix Health, Nouscom, Avation Medical, Pretzel Therapeutics, Cadence Neuroscience and Freya Biosciences.
https://www.angeliniventures.com/
About 15th Rock
15th Rock is a venture capital firm dedicated to investing in human augmentation and information technology to foster a prosperous society in an era where living to 100 years is increasingly common. Human augmentation aims to empower individuals by enhancing physical abilities, unlocking previously unattainable skills, and expanding life choices. This is achieved through the integration of advanced technologies such as AI, robotics, electronics, AR/VR, and brain-machine interfaces.
About PMV
The Flemish investment company PMV is shaping the future of the Flemish economy. PMV finances promising companies from the very start, through to growth and internationalisation. PMV offers tailor-made financial solutions to entrepreneurs with a good business plan and a strong management team. It does so with capital, loans and guarantees. It also realises, with and for the government, and other partners, projects that are important for prosperity and well-being in Flanders. PMV has a portfolio with 1.8 billion euros under management. More information via www.pmv.eu
About EQT Life Sciences
EQT Life Sciences was formed in 2022 following the integration of LSP, a leading European life sciences venture capital firm, into the EQT platform. As LSP, the firm raised over EUR 3.0 billion and supported the growth of more than 150 companies since it started to invest over 30 years ago. With a dedicated team of highly experienced investment professionals coming from backgrounds in medicine, science, business, and finance, EQT Life Sciences backs entrepreneurs who have ideas that could truly make a difference for patients. The team combines deep sector knowledge, analytical skills, and investment experience to provide the added value that entrepreneurs seek. For more information, go to eqtgroup.com/private-capital/life-sciences/
About Balz Halter
Balz Halter is the majority shareholder and Chairman of Halter Group Ltd., a leading Swiss construction and real estate company. A visionary entrepreneur, Halter specializes in urban development, construction, and innovative building technologies.
Liesbeth Pyck
[1]https://www.census.gov/content/dam/Census/library/publications/2020/demo/p25-1144.pdf
[2]https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Ageing_Europe_-_looking_at_the_lives_of_older_people_in_the_EU
[3] https://www.stat.go.jp/english/data/jinsui/index.html
[4] Nobi impact analyse: uitgevoerd in vijf zorginstellingen over 2.817 bewonersdagen
